From inflammation to cancer
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The participation of inflammation in the progression of cancer for many years have been the subject of research. METHODS: In the 19th century, there was evidence that an acute inflammation may inhibit the development of cancer. However, chronic inflammation affects the progression of the disease. RESULTS: Today, it is known that inflammation and cancer use similar mechanisms of development such as severe cell proliferation or angiogenesis. It has been shown that prolonged presence of inflammatory cells and factors in the tumor microenvironment can accelerate its growth and inhibit apoptosis of transformed cells. CONCLUSION: In this article we present a brief history of the discovery mechanisms and potential links between acute and chronic inflammation and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Changes of IRFs are not limited to neuropsychiatric disorders; they are also reported in patients with cardiovascular and metabolic diseases66, as well as cancer67,68.”
From Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses (2019) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755 · cited 2×
“Currently, we know that irrespective of the triggering agent, tissue damage activates signals that initiate and support the immune response of the host, able to eliminate a damaging agent and to repair tissues [8].”
BackgroundMizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472 · cited 1×
“Other cells include monocytes and lymphocytes initiating healing and generation of immunological memory [25].”
BackgroundTumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“Moreover, the author observed that the cells involved in inflammation also infiltrated cancer tissue [2, 3] and defined cancer as a ‘‘wound that does not heal’’.”
BackgroundGetting to the site of inflammation: the leukocyte adhesion cascade updated
Ley, K., Laudanna, C., Cybulsky, M. I., & Nourshargh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2156 · Cited by 4,354 · cited 1×
“Apart from PECAM-1, such distribution is also characteristic of CD99 protein [21, 22].”
BackgroundNuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Widespread changes in protein synthesis induced by microRNAs
Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R., & Rajewsky, N. (2008) · Nature · doi:10.1038/nature07228 · Cited by 3,429
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256 · cited 1×
“This is associated, among others, with the production by the transforming cancer cells of many cytokines and chemokines which attract various populations of immune cells, including macrophages, neutrophils, adipose cells, dendritic cells and T, B and NK cells, which in turn infiltrate tumor tissues and form tumor micr…”
BackgroundInflammation and cancer: how hot is the link?
Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.029 · Cited by 1,312
Inflammation and cancer: advances and new agents
Crusz, S. M., & Balkwill, F. R. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.105 · Cited by 1,184
Bidirectional Transmembrane Signaling by Cytoplasmic Domain Separation in Integrins
Kim, M., Carman, C. V., & Springer, T. A. (2003) · Science · doi:10.1126/science.1084174 · Cited by 786 · cited 1×
“During activation changes take place in the arrangement of these proteins, which allows binding to a ligand [15].”
BackgroundCancer-related inflammation: Common themes and therapeutic opportunities
Balkwill, F. R., & Mantovani, A. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.12.005 · Cited by 685 · cited 2×
“It is currently estimated that approximately 25 % of cancers are associated with chronic inflammation caused by infection or physicochemical agents [30].”
BackgroundWoodfin, A., Voisin, M.-B., Beyrau, M., Colom, B., Caille, D., Diapouli, F.-M., Nash, G. B., Chavakis, T., Albelda, S. M., Rainger, G. E., et al. (2011) · Nature Immunology · doi:10.1038/ni.2062 · Cited by 590 · cited 1×
“During diapedesis leukocytes assume the amoeboid shape as a result of cytoskeletal alterations and push their way between endothelial cells [19].”
BackgroundDNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice
Meira, L. B., Bugni, J. M., Green, S. L., Lee, C.-W., Pang, B., Borenshtein, D., Rickman, B. H., Rogers, A. B., Moroski-Erkul, C. A., McFaline, J. L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35073 · Cited by 548 · cited 3×
“The major role of inflammation in mutagenesis can be exemplified by the development of colorectal adenocarcinoma induced by inflammation and the action of an irritant, dextran sodium sulfate (DSS) [35].”
BackgroundInfluentialSakurai, T., He, G., Matsuzawa, A., Yu, G.-Y., Maeda, S., Hardiman, G., & Karin, M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.016 · Cited by 487
Zarbock, A., Ley, K., McEver, R. P., & Hidalgo, A. (2011) · Blood · doi:10.1182/blood-2011-07-343566 · Cited by 481
Pericytes support neutrophil subendothelial cell crawling and breaching of venular walls in vivo
Proebstl, D., Voisin, M.-B., Woodfin, A., Whiteford, J., D’Acquisto, F., Jones, G. E., Rowe, D., & Nourshargh, S. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111622 · Cited by 467 · cited 1×
“The process occurs when the inflammatory cell CD11a binds to pericyte-ICAM-1 to allow leukocytes to reach the sites with the lowest density of the collagen network [23].”
BackgroundCellular Pathology As Based upon Physiological and Pathological Histology.
(1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-1-157_2 · Cited by 455
Locomotion of monocytes on endothelium is a critical step during extravasation
Schenkel, A. R., Mamdouh, Z., & Muller, W. A. (2004) · Nature Immunology · doi:10.1038/ni1051 · Cited by 439 · cited 2×
“Leukocytes have on their surface members of the b2 family (CD18), whose main ligands, i.e., the immunoglobulin-like molecules, ICAM-1 and ICAM-2, are present on the endothelium [16].”
BackgroundGetting Leukocytes to the Site of Inflammation
Muller, W. A. (2013) · Veterinary Pathology · doi:10.1177/0300985812469883 · Cited by 400 · cited 1×
“This is associated with partial leukocyte integrin activation [13].”
BackgroundThe Complex Role of Neutrophils in Tumor Angiogenesis and Metastasis
Liang, W., & Ferrara, N. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0313 · Cited by 347 · cited 1×
“In tumor microenvironment, cells communicate with one another either by direct contact or production of various mediators [40].”
BackgroundAs Based upon Physiological and Pathological Histology: CELLULAR PATHOLOGY.
VIRCHOW, R. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1989.tb02747.x · Cited by 345
Inflammation and the Microcirculation
Granger, D. N., & Senchenkova, E. Y. (2010) · Colloquium Series on Integrated Systems Physiology From Molecule to Function · doi:10.4199/c00013ed1v01y201006isp008 · Cited by 285
Mitroulis, I., Alexaki, V. I., Kourtzelis, I., Ziogas, A., Hajishengallis, G., & Chavakis, T. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.008 · Cited by 283 · cited 1×
“, the immunoglobulin-like molecules, ICAM-1 and ICAM-2, are present on the endothelium [16].”
BackgroundCellular pathology as based upon physiological and pathological histology ...
Virchow, R. (1863) · J.B. Lippincott eBooks · doi:10.5962/bhl.title.32770 · Cited by 217
Eiró, N. (2012) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v4.i3.62 · Cited by 173
Interleukins 1 and 6 as main mediators of inflammation and cancer
Dmitrieva, O., Shilovskiy, I. P., Khaitov, M. R., & Grivennikov, S. I. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916020024 · Cited by 160 · cited 1×
“toxins) stimulate attraction of circulating leukocytes to the site of inflammation [9].”
BackgroundOkazaki, I., Kotani, A., & Honjo, T. (2007) · Advances in immunology · doi:10.1016/s0065-2776(06)94008-5 · Cited by 158
What is “inflammation”? Are we ready to move beyond Celsus?
Scott, A., Khan, K. M., Cook, J. L., & Duronio, V (2004) · British Journal of Sports Medicine · doi:10.1136/bjsm.2003.011221 · Cited by 154 · cited 1×
“The invention of a microscope was a breakthrough in their understanding, making it possible to observe the microcirculatory changes in inflamed tissues [5].”
BackgroundBladder Cancer Immunotherapy: BCG and Beyond
Askeland, E. J., Newton, M. R., O’Donnell, M. A., & Luo, Y. (2012) · Advances in Urology · doi:10.1155/2012/181987 · Cited by 145 · cited 2×
“Induced immune reaction is associated with cytokine secretion, including interleukin-1 (IL-1), IL-2, IL5, IL-6, IL-8, IL-10, IL-12, IL-15, IL-18, TNF-a, GM-CSF and interferon (IFN)-c [28].”
BackgroundInflammatory Cells and Oxygen Radicals
Nagata, M. (2005) · Current Drug Target -Inflammation & Allergy · doi:10.2174/1568010054526322 · Cited by 138 · cited 1×
“For instance, the production of proinflammatory prostaglandins is decreased and the generation of anti-inflammatory lipoxins that attract monocytes, IL-10 or TGF, is increased [24].”
BackgroundSumagin, R., & Sarelius, I. H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903319 · Cited by 95 · cited 1×
“The surface of lymphocytes and monocytes exhibits the b1 family integrins (VLA-4, CD49d/CD29, a4b1), which bind to VCAM-1 molecules [17].”
Background(2001) · Springer eBooks · doi:10.1007/978-1-4614-7512-5 · Cited by 92
CD99 and CD99L2 act at the same site as, but independently of, PECAM-1 during leukocyte diapedesis
Bixel, M. G., Li, H., Petri, B., Khandoga, A. G., Khandoga, A., Zarbock, A., Wolburg-Buchholz, K., Wolburg, H., Sorokin, L., Zeuschner, D., et al. (2010) · Blood · doi:10.1182/blood-2009-12-256388 · Cited by 79 · cited 1×
“Apart from PECAM-1, such distribution is also characteristic of CD99 protein [21, 22].”
Backgroundl-Selectin – A dynamic regulator of leukocyte migration
Wedepohl, S., Beceren‐Braun, F., Riese, S. B., Buscher, K., Enders, S., Bernhard, G., Kilian, K., Blanchard, V., Dernedde, J., & Tauber, R. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.02.007 · Cited by 77 · cited 1×
“However, any adequately modified glycoprotein can be a potential selectin receptor, like CD34, which having been transformed on the endothelial surface becomes L-selectin receptor on leukocytes [11].”
BackgroundLeukocyte integrin activation and deactivation: novel mechanisms of balancing inflammation
Zarbock, A., Kempf, T., Wollert, K. C., & Vestweber, D. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0835-2 · Cited by 70 · cited 1×
“Contact of these proteins with specific leukocyte receptors (a subgroup of receptors conjugated with G protein) causes the transmission of a signal that activates integrins present on the inflammatory cells [14].”
BackgroundSalem, M. L., Attia, Z. I., & Galal, S. (2015) · Journal of Advanced Research · doi:10.1016/j.jare.2015.06.001 · Cited by 31 · cited 2×
“, acute phase response of moderate intensity (chronic inflammation) is involved in neoplastic transformation and stimulation of cancer growth [29].”
BackgroundInflammation in cancer: a therapeutic target?
Trinchieri, G. (2011) · PubMed · Cited by 30
The relationship between inflammation and cancer is analogous to that between fuel and fire.
Aggarwal, B. B., & Sung, B. (2011) · PubMed · Cited by 24
E-selectin: Its Role in Cancer and Potential as a Biomarker
Mann, A. P., & Tanaka, T. (2012) · Translational Medicine · doi:10.4172/2161-1025.s1-002 · Cited by 15 · cited 1×
“A few hours after activation, E-selectin appears on the endothelial surface [12].”
BackgroundZapalenie (ostre) jako reakcja korzystna dla organizmu - historia badań a najnowsze osiągnięcia
Kołaczkowska, E. (2007) · Jagiellonian University Repository (Jagiellonian University) · Cited by 12
Missing link: inflammation and ovarian cancer
Pejovic, T. B., & Nezhat, F. R. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70203-0 · Cited by 11
Research works printed but not linked: 2
- Kołaczkowska E Acute inflammation as a beneficial process—history and recent developments Kosmos 2007 56 27 38
- Muller WA (2007) PECAM: Regulating the start of diapedesis. In: Adhesion molecules: function and inhibition. Progress in inflammation research, pp 201–220. doi:10.1007/978-3-7643-7975-9-8 · doi:10.1007/978-3-7643-7975-9-8
Cited by
Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements
Aggarwal, V., Tuli, H., Varol, A., Thakral, F., Yerer, M., Sak, K., Varol, M., Jain, A., Khan, M., & Sethi, G. (2019) · Biomolecules · doi:10.3390/biom9110735 · Cited by 1,221
“The intricate relationship between cancer and, prolonged inflammation has been thoroughly investigated since Virchow’s hypothesis [28].”
BackgroundInflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome
Mihai, S., Codrici, E., Popescu, I. D., Enciu, A.-M., Albulescu, L., Necula, L. G., Mambet, C., Anton, G., & Tanase, C. (2018) · Journal of Immunology Research · doi:10.1155/2018/2180373 · Cited by 673
“The sustained presence of inflammatory cells in the tumour milieu can stimulate tumour growth, hindering apoptosis of atypically transformed cells [91].”
BackgroundRole of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions
Mohammad, S., & Thiemermann, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594150 · Cited by 585
Yuan, N., Chen, Y., Xia, Y., Dai, J., & Liu, C. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0570-y · Cited by 428
Tight Junction Proteins and Signaling Pathways in Cancer and Inflammation: A Functional Crosstalk
Bhat, A. A., Uppada, S., Achkar, I. W., Hashem, S., Yadav, S. K., Shanmugakonar, M., Al-Naemi, H. A., Haris, M., & Uddin, S. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01942 · Cited by 400
“As TJ barrier dysfunction and inflammation are tightly associated with each other, equally inflammation and cancer are closely linked (Coussens and Werb, 2002; Raposo et al., 2015; Korniluk et al., 2017).”
Background
Metadata
- Authors
- Korniluk, A., Koper, O., Kemona, H., & Dymicka-Piekarska, V.
- Affiliations
- Medical University of Białystok (PL)
- Corresponding author
- Dymicka-Piekarska, V.
- Venue
- Irish Journal of Medical Science (1971 -)
- Published
- 2016-05-07
- Volume
- 186
- Issue
- 1
- Pages
- 57-62
- ISSN
- 0021-1265 (ISSN-L)
- 1863-4362
- PMC
- PMC5323483
- OpenAlex
- W2345630246
- Cited by
- 282
- References
- 43
- Citations by year
- 2026: 8 · 2025: 23 · 2024: 24 · 2023: 36 · 2022: 46 · 2021: 50 · 2020: 30 · 2019: 33 · 2018: 19 · 2017: 9 · 2016: 4
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Irish Journal of Medical Science (1971 -) (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Uniwersytet Medyczny w Bialymstoku (PL) (N/ST/ZB/15/002/2209)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Keywords
- inflammation, tumor progression, chronic inflammation, acute inflammation, tumor microenvironment, angiogenesis, cell proliferation, apoptosis
- MeSH terms
- Humans, Inflammation, Neoplasms, Neovascularization, Pathologic, Apoptosis, Disease Progression, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.